Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (81-90 of 787) with videos related to

Pageof 79
Sort By:
Chemsuschem|August 30, 2025
Unlocking the Second Electron in the Electrochemical Delithiation/Lithiation of Copper (2,5-Dilithium-oxy)-Terephthalate via a Carbon-Supported Electrode ArchitectureAswadh Shyma Sajeevan, Daniel Brandell, Philippe Moreau, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Firstline treatment and maintenance in newly diagnosed multiple myeloma patientsMurielle Roussel, Thierry Facon, Philippe Moreau, et al.
Haematologica|November 4, 2005
High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphomaStéphane Vigouroux, Fanny Gaillard, Philippe Moreau, et al.
Haematologica|May 4, 2006
Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single centerStéphane Vigouroux, Odile Morin, Philippe Moreau, et al.
Clinical Nuclear Medicine|June 27, 2025
Unusual Sole Extramedullary Diffuse Kidney Involvement in Multiple Myeloma Initial Workup Using 2-[ 18 F]FDG-PET/CT ImagingBastien Jamet, Cyrille Touzeau, Chloe Antier, et al.
Critical Reviews in Oncology/Hematology|December 28, 2017
A question of class: Treatment options for patients with relapsed and/or refractory multiple myelomaGordon Cook, Sonja Zweegman, María-Victoria Mateos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2026
Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessmentBastien Jamet, Cyrille Touzeau, Chloé François, et al.
British Journal of Haematology|June 11, 2021
Pembrolizumab combined with carfilzomib and low-dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE-023 studyPhilippe Moreau, Razi Ghori, Mohammed Farooqui, et al.
Nature Reviews. Clinical Oncology|November 26, 2014
Current treatment landscape for relapsed and/or refractory multiple myelomaMeletios A Dimopoulos, Paul G Richardson, Philippe Moreau, et al.
Seminars in Hematology|July 26, 2011
Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?Steven Le Gouill, Mohamad Mohty, Thierry Guillaume, et al.
Pageof 79

Showing results (81-90 of 787) with videos related to

Sort By:
Pageof 79
Chemsuschem|August 30, 2025
Unlocking the Second Electron in the Electrochemical Delithiation/Lithiation of Copper (2,5-Dilithium-oxy)-Terephthalate via a Carbon-Supported Electrode ArchitectureAswadh Shyma Sajeevan, Daniel Brandell, Philippe Moreau, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Firstline treatment and maintenance in newly diagnosed multiple myeloma patientsMurielle Roussel, Thierry Facon, Philippe Moreau, et al.
Haematologica|November 4, 2005
High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphomaStéphane Vigouroux, Fanny Gaillard, Philippe Moreau, et al.
Haematologica|May 4, 2006
Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single centerStéphane Vigouroux, Odile Morin, Philippe Moreau, et al.
Clinical Nuclear Medicine|June 27, 2025
Unusual Sole Extramedullary Diffuse Kidney Involvement in Multiple Myeloma Initial Workup Using 2-[ 18 F]FDG-PET/CT ImagingBastien Jamet, Cyrille Touzeau, Chloe Antier, et al.
Critical Reviews in Oncology/Hematology|December 28, 2017
A question of class: Treatment options for patients with relapsed and/or refractory multiple myelomaGordon Cook, Sonja Zweegman, María-Victoria Mateos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2026
Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessmentBastien Jamet, Cyrille Touzeau, Chloé François, et al.
British Journal of Haematology|June 11, 2021
Pembrolizumab combined with carfilzomib and low-dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE-023 studyPhilippe Moreau, Razi Ghori, Mohammed Farooqui, et al.
Nature Reviews. Clinical Oncology|November 26, 2014
Current treatment landscape for relapsed and/or refractory multiple myelomaMeletios A Dimopoulos, Paul G Richardson, Philippe Moreau, et al.
Seminars in Hematology|July 26, 2011
Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?Steven Le Gouill, Mohamad Mohty, Thierry Guillaume, et al.
Pageof 79